Correlation Between Enlivex Therapeutics and Neutra Corp

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Neutra Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Neutra Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Neutra Corp, you can compare the effects of market volatilities on Enlivex Therapeutics and Neutra Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Neutra Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Neutra Corp.

Diversification Opportunities for Enlivex Therapeutics and Neutra Corp

-0.07

Correlation Coefficient

Enlivex Therapeutics  Neutra Corp

Good diversification

The 3 months correlation between Enlivex and Neutra is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Neutra Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neutra Corp and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Neutra Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neutra Corp has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Neutra Corp go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Neutra Corp

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Neutra Corp. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 4.22 times less risky than Neutra Corp. The stock trades about -0.01 of its potential returns per unit of risk. The Neutra Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.05  in Neutra Corp on September 30, 2024 and sell it today you would lose (0.03) from holding Neutra Corp or give up 60.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Enlivex Therapeutics  vs.  Neutra Corp

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Neutra Corp

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neutra Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Neutra Corp reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enlivex Therapeutics and Neutra Corp

The main advantage of trading using opposite Enlivex Therapeutics and Neutra Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Neutra Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neutra Corp will offset losses from the drop in Neutra Corp's long position.

The idea behind Enlivex Therapeutics and Neutra Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.